New Brunswick, New Jersey-based Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. The company has a market cap of $554.1 billion and operates in two segments, Innovative Medicine and MedTech.
Companies with a market capitalization of $200 billion or more are typically referred to as "mega-cap stocks." JNJ fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the general drug manufacturers industry.